Advances in regenerative cardiology: Stem cells versus bioartificial tissues

Simple item page
dc.contributor.authorJenyfer María Fuentes‐Mendoza
dc.contributor.authorJuan Manuel Muñoz Moreno
dc.contributor.authorMarcio José Concepción‐Zavaleta
dc.contributor.authorLuis Alberto Concepción‐Urteaga
dc.contributor.authorJosé Paz‐Ibarra
dc.contributor.authorRoger Gonzales‐Valdivieso
dc.contributor.authorFernanda Ginebra Castillo‐Velásquez
dc.contributor.authorAngie Sofía Burgos‐Castillo
dc.contributor.authorRegina Garza‐Boullosa
dc.contributor.authorVanesa Daniela Núñez‐Pérez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:06:20Z
dc.date.available2026-03-22T21:06:20Z
dc.date.issued2025
dc.description.abstractSC- and BAT-based therapies offer innovative avenues for repairing damaged myocardium. Their application could revolutionise treatment strategies for heart failure and post-infarction remodelling. However, clinical translation requires addressing immune compatibility, arrhythmic risk and manufacturing limitations. Interdisciplinary collaboration and regulatory standardisation are essential for their future clinical adoption.
dc.identifier.doi10.1111/eci.70101
dc.identifier.urihttps://doi.org/10.1111/eci.70101
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85959
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEuropean Journal of Clinical Investigation
dc.sourceUniversidad Científica del Sur
dc.subjectDecellularization
dc.subjectRegenerative medicine
dc.subjectStem cell
dc.subjectTissue engineering
dc.subjectMedicine
dc.subjectMyocardial infarction
dc.subjectMesenchymal stem cell
dc.subjectHeart failure
dc.subjectCell therapy
dc.subjectEmbryonic stem cell
dc.titleAdvances in regenerative cardiology: Stem cells versus bioartificial tissues
dc.typereview

Files

Collections

Artículo Científico Publicado